Abstract
This paper will provide a comparison of classical endpoints like stroke and mortality versus biochemical (non-STEMI) myocardial infarction and DW-MRI new brain lesions and will discuss the importance of cranial nerve lesion in CEA. An overview of possible endpoints of future randomized clinical trials will be given.
| Original language | English |
|---|---|
| Pages (from-to) | 325-331 |
| Journal | Journal of cardiovascular surgery |
| Volume | 60 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 1 Jun 2019 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Clinical and surrogate endpoints in future studies on outcome of carotid revascularization'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver